Conference
Tolerability and efficacy of chemotherapy in older men with metastatic castrate-resistant prostate cancer (mCRPC) in the TAX 327 trial.
Authors
Seruga B; Horgan AM; Pond GR; Alibhai SMH; Amir E; De Wit R; Eisenberger MA; Tannock I
Volume
29
Pagination
pp. 4530-4530
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2011
DOI
10.1200/jco.2011.29.15_suppl.4530
Conference proceedings
Journal of Clinical Oncology
Issue
15_suppl
ISSN
0732-183X